NO891071D0 - Fremgangsmaate for fremstilling av 4,5,6,7-tetrahydro-isotiazolo(4,5-c)-pyridinderivater og isomere. - Google Patents

Fremgangsmaate for fremstilling av 4,5,6,7-tetrahydro-isotiazolo(4,5-c)-pyridinderivater og isomere.

Info

Publication number
NO891071D0
NO891071D0 NO891071A NO891071A NO891071D0 NO 891071 D0 NO891071 D0 NO 891071D0 NO 891071 A NO891071 A NO 891071A NO 891071 A NO891071 A NO 891071A NO 891071 D0 NO891071 D0 NO 891071D0
Authority
NO
Norway
Prior art keywords
preparation
isomers
isotiazolo
tetrahydro
procedure
Prior art date
Application number
NO891071A
Other languages
English (en)
Other versions
NO177145C (no
NO891071L (no
NO177145B (no
Inventor
Povl Krogsgaard-Larsen
Erik Falch
Henrik Pedersen
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888806013A external-priority patent/GB8806013D0/en
Priority claimed from GB888822564A external-priority patent/GB8822564D0/en
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of NO891071D0 publication Critical patent/NO891071D0/no
Publication of NO891071L publication Critical patent/NO891071L/no
Publication of NO177145B publication Critical patent/NO177145B/no
Publication of NO177145C publication Critical patent/NO177145C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
NO891071A 1988-03-14 1989-03-13 Analogifremgangsmåte for fremstilling av 4,5,6,7-tetrahydroisotiazolo[4,5-cÅ-pyridinderivater og isomere NO177145C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888806013A GB8806013D0 (en) 1988-03-14 1988-03-14 Heterocyclic compounds
GB888822564A GB8822564D0 (en) 1988-09-26 1988-09-26 Heterocyclic compounds

Publications (4)

Publication Number Publication Date
NO891071D0 true NO891071D0 (no) 1989-03-13
NO891071L NO891071L (no) 1989-09-15
NO177145B NO177145B (no) 1995-04-18
NO177145C NO177145C (no) 1995-07-26

Family

ID=26293631

Family Applications (1)

Application Number Title Priority Date Filing Date
NO891071A NO177145C (no) 1988-03-14 1989-03-13 Analogifremgangsmåte for fremstilling av 4,5,6,7-tetrahydroisotiazolo[4,5-cÅ-pyridinderivater og isomere

Country Status (17)

Country Link
US (1) US4923880A (no)
EP (1) EP0336555B1 (no)
JP (1) JPH01275585A (no)
AT (1) ATE81130T1 (no)
AU (1) AU630085B2 (no)
CA (1) CA1337201C (no)
DE (1) DE68903019T2 (no)
DK (1) DK169676B1 (no)
ES (1) ES2052901T3 (no)
FI (1) FI91411C (no)
GR (1) GR3006606T3 (no)
IE (1) IE62782B1 (no)
IL (1) IL89351A0 (no)
NO (1) NO177145C (no)
NZ (1) NZ228182A (no)
PT (1) PT89992B (no)
ZA (1) ZA891769B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2645862B1 (fr) * 1989-04-18 1991-07-12 Esteve Labor Dr Derives d'isothiazolo-pyrydone azetidinyl substitues, leur preparation et leur application en tant que medicaments
US5574028A (en) * 1994-10-31 1996-11-12 Eli Lilly And Company Method for treating anxiety
EA199800533A1 (ru) * 1995-12-07 1999-02-25 Эли Лилли Энд Компани Композиция для лечения боли
US20050137222A1 (en) * 2003-12-18 2005-06-23 H. Lundbeck A/S Treatment of insomnia in human patients
US20110098777A1 (en) * 2009-10-23 2011-04-28 Silverstone Leon M Method and apparatus for treatment of neurodegenerative diseases including depression, mild cognitive impairment, and dementia
CA2977437C (en) 2015-03-24 2023-07-04 H. Lundbeck A/S Manufacture of 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8314391D0 (en) * 1983-05-24 1983-06-29 Kefalas As Heterocyclic compounds
IL87709A (en) * 1987-09-16 1992-11-15 Pfizer Process for preparing haloalkyl thiazoles and some such novel haloalkyl thiazoles
DE3820775A1 (de) * 1988-06-20 1989-12-21 Thomae Gmbh Dr K Neue 4,5,7,8-tetrahydro-6h-thiazolo(5,4,-d)azepine, ihre herstellung und ihre verwendung als arzneimittel
JP3054738B2 (ja) * 1988-07-22 2000-06-19 武田薬品工業株式会社 チアゾロ［５，４―ｂ］アゼピン誘導体

Also Published As

Publication number Publication date
NO177145C (no) 1995-07-26
FI891155A0 (fi) 1989-03-10
AU630085B2 (en) 1992-10-22
PT89992A (pt) 1989-11-10
NZ228182A (en) 1990-08-28
EP0336555B1 (en) 1992-09-30
DK121789D0 (da) 1989-03-14
EP0336555A1 (en) 1989-10-11
ATE81130T1 (de) 1992-10-15
JPH01275585A (ja) 1989-11-06
FI91411C (fi) 1994-06-27
NO891071L (no) 1989-09-15
ZA891769B (en) 1989-12-27
ES2052901T3 (es) 1994-07-16
GR3006606T3 (no) 1993-06-30
FI91411B (fi) 1994-03-15
PT89992B (pt) 1994-05-31
FI891155A (fi) 1989-09-15
IE890648L (en) 1989-09-14
DE68903019D1 (de) 1992-11-05
IL89351A0 (en) 1989-09-10
CA1337201C (en) 1995-10-03
IE62782B1 (en) 1995-02-22
AU3126289A (en) 1989-09-14
DK169676B1 (da) 1995-01-09
US4923880A (en) 1990-05-08
DE68903019T2 (de) 1993-07-08
NO177145B (no) 1995-04-18
DK121789A (da) 1989-09-15

Similar Documents

Publication Publication Date Title
TNSN90032A1 (fr) Derives de n-(3-hydroxy-4-piperidinyl) (dihydro-benzofuranne, dihydro-2h-benzopyranne ou dihydro-benzodioxin) carboxamide, et leur procede de preparation
NO912410D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocyklen-derivater.
ATE121939T1 (de) Ascorbinsäure-tocopheryl-phosphatdiester zur hemmung der maillard-reaktion.
HUT67039A (en) Process for preparing 2-substituted saccharin derivatives and pharmaceutical compositions containing them
FI884553A (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 9-aminotetrahydroakridiinijohdannaisten valmistamiseksi
YU224790A (sh) Aminokarbonil karbamati, sorodni fizostigminu/in postopek za njihovo pripravo in njihova uporaba kot zdravila
ATE55981T1 (de) Phenylserin-derivate und verfahren zu ihrer herstellung.
DE69501359T2 (de) Verwendung von Phosphatdiestern zur Behandlung von Erkrankungen der Retina
NO891071L (no) Fremgangsmaate for fremstilling av 4,5,6,7-tetrahydro-isotiazolo(4,5-c)-pyridinderivater og isomere.
NO900342D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 3-fenyl-5,6-dihydrobenz(c)acridin-7-carboxylsyrer og beslektede forbindelser.
IL60217A (en) 4'-deoxyparomomycin derivatives,process for their preparation and pharmaceutical compositions containing them
NO169391C (no) Analogifremgangsmaate for fremstilling av et terapeutisk aktivt (-)-cis-quinuklidin og syreaddisjonssalter derav
NZ231293A (en) 1,2,3,4-tetrahydro-1,9-acridinediamines, homologues thereof, and pharmaceutical compositions
DK166281C (da) Tetrahydroisoxazoloe4,5-caapyridin derivater og farmaceutisk acceptable syreadditionssalte deraf, farmaceutiske praeparater indeholdende disse forbindelser, og fremgangsmaade til deres fremstilling
DK0400916T3 (da) 4,5,6,11-Tetrahydrobenzo(6,7)-cycloocta(1,2-b)-thiophen-6,11-iminer og 6,11-dihydrobenzo(6,7)- cycloocta(1,2-b)thiophen-6,11 iminer
DK0573260T3 (da) Nye alkaloidderivater, deres anvendelse og farmaceutiske formuleringer, der indeholder dem